Skip to content
  • About
  • Team
  • Clinical Studies
  • Investing
  • Press & Media
  • Contact
Menu
  • About
  • Team
  • Clinical Studies
  • Investing
  • Press & Media
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT

Cookie policy

Albert Labs respects your privacy and is committed to transparency. Please find below details of our use of cookies on the Albert Labs website.

Cookies are text files of information, downloaded to your computer or mobile device. The information is stored in the form of a small data file written to your hard drive. These contain information which enables us to personalise your use of our website and present you with relevant content.

Access to the secure areas of the website is dependent upon the use of cookies.

Cookies also enable us to analyse and improve the navigation and content of the website. Most browsers allow the user to control the cookies, including whether or not to accept them and how to remove them. If you disable cookies on your computer or device, some of the features of our website may be unavailable to you.

At the Albert Labs, our primary use of cookies is to identify which web pages are accessed. This helps us to analyse and improve the navigation and content of the website.

We do this mostly through traffic log cookies and analytics services provided by Google Analytics.

We also use cookies tracked through Google Analytics to optimise our Google search rankings in order to help users find relevant content.

We have conducted an audit of the cookies used on the new Albert Labs website using a compliant cookie audit tool. We browsed a number of pages on the site to build up an accurate list of cookies used.

Cookies used in the Albert Labs website

The table below describes the cookies being used in the website now. As the website develops, cookie usage may change and this list will change – we will update this page to include any changes:

accelerated access to safe and effective psychedelic-assisted therapy for patients with urgent, unmet needs.

  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
Menu
  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
  • About
  • Team
  • Clinical Studies
  • Investing
  • Press & Media
  • Contact
Menu
  • About
  • Team
  • Clinical Studies
  • Investing
  • Press & Media
  • Contact

© 2021 Albert Labs. All Rights Reserved

Canada – 6996, Merritt Ave, Burnaby, BC, V5J 4R6

United Kingdom – 61 Mosley Street, Manchester, M2 3HZ

  • About
  • Team
  • Clinical Studies
  • Investing
  • Press & Media
  • Contact
Menu
  • About
  • Team
  • Clinical Studies
  • Investing
  • Press & Media
  • Contact
Twitter Linkedin Youtube Envelope
CSE:ABRT
FSE: VB50
CSE:ABRT
FSE: VB50

About Albert Labs

We’re a pharmaceutical focused, natural drug development company using an accelerated regulatory pathway to deliver faster access to novel mental health therapies for patients with unmet needs

Twitter Linkedin Youtube Envelope
Sign Up

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.

Twitter
Linkedin
Youtube
Envelope

Latest Press Release

Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101

Read more

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.